Contineum Therapeutics Income Statement (2023-2026) | CTNM

Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter) 18.08M2.35M2.38M18.99M25.73M19.35M25.87M28.04M23.10M27.70M37.34M
Revenue & cost
Revenue (Quarter) 50.00M
Operating items
Research & Development (Quarter) 3.63M9.46M6.50M8.01M7.78M7.90M9.73M13.02M13.71M14.06M10.99M12.76M11.65M
Selling, General & Administrative (Quarter) 1.48M1.60M1.57M1.66M2.15M3.04M3.25M4.03M4.40M3.84M3.94M4.36M5.26M
Operating Expenses (Quarter) 5.12M11.06M8.07M9.68M9.93M10.94M12.97M17.05M18.11M17.90M14.93M17.11M16.90M
Operating Income (Quarter) -5.12M38.94M-8.07M-9.68M-9.93M-10.94M-12.97M-17.05M-18.11M-17.90M-14.93M-17.11M-16.90M
EBIT (Quarter) -5.12M38.94M-8.07M-9.68M-9.93M-10.94M-12.97M-17.05M-18.11M-17.90M-14.93M-17.11M-16.90M
Non-operating items
Interest & Investment Income (Quarter) 0.07M-0.06M-0.02M4.62M-0.17M-0.07M2.74M-0.49M2.25M-0.02M0.12M-6.05M2.50M
Other Non Operating Income (Quarter) -0.02M-0.08M-0.04M-0.05M-0.01M-0.08M-0.03M-0.05M-0.13M-0.17M0.18M-0.05M-0.06M
Non Operating Income (Quarter) 0.29M3.36M1.70M1.75M1.51M1.94M2.71M2.48M2.12M1.86M2.41M1.96M2.45M
Net income details
EBT (Quarter) -4.82M42.30M-6.37M-7.93M-8.42M-9.01M-10.27M-14.56M-21.77M-20.83M-34.67M-24.02M-38.45M
Tax Provisions (Quarter) 0.73M-0.10M-0.59M
Profit After Tax (Quarter) -4.82M41.56M-6.28M-7.57M-8.42M-9.01M-10.27M-14.60M-15.99M-16.04M-12.79M-15.18M-14.50M
Income from Continuing Operations (Quarter) -4.82M41.57M-6.27M-7.33M-8.42M-9.01M-10.27M-14.56M-21.77M-20.83M-34.67M-24.02M-38.45M
Consolidated Net Income (Quarter) -4.82M41.57M-6.27M-7.33M-8.42M-9.01M-10.27M-14.56M-21.77M-20.83M-34.67M-24.02M-38.45M
Income towards Parent Company (Quarter) -4.82M41.57M-6.27M-7.33M-8.42M-9.01M-10.27M-14.56M-21.77M-20.83M-34.67M-24.02M-38.45M
Net Income towards Common Stockholders (Quarter) -4.82M41.57M-6.27M-7.33M-8.42M-9.01M-10.27M-14.56M-15.99M-16.04M-12.79M-24.02M-38.45M
Additional items
EPS (Basic) (Quarter) -2.1218.11-0.35-3.17-3.55-0.39-0.40-0.75-0.62-0.62-0.45-0.87-1.03
EPS (Diluted) (Quarter) -2.1211.84-2.70-2.16-3.55-0.39-0.40-0.75-0.62-0.62-0.49-0.87-1.03
Shares Outstanding (Quarter) 2.28M2.30M18.08M2.31M2.37M23.36M25.73M19.35M25.87M25.90M28.12M27.70M37.34M
Shares Outstanding (Diluted) (Quarter) 2.28M3.51M2.32M3.40M2.37M23.36M25.73M19.35M25.87M25.87M25.87M27.70M37.34M
EBITDA (Quarter) -5.12M38.94M-8.07M-9.68M-9.93M-10.94M-12.97M-17.05M-18.11M-17.90M-14.93M-17.11M-16.90M
Interest Expenses (Quarter) 0.09M0.12M27.02M0.13M5.91M2.91M19.86M0.85M24.05M
Tax Rate (Quarter) 1.721.577.50